Though low cost cards might help reduce the stress of substantial drug expenditures within the short-term, they do not tackle the systemic difficulties driving up prescription rates within the U.S. Broader coverage adjustments could deal with the root results in of mounting drug selling prices, for instance lack of transparency in pricing plus the